These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 96355)

  • 21. Parasitology. Malaria vaccines: back to the future?
    Waters AP; Mota MM; van Dijk MR; Janse CJ
    Science; 2005 Jan; 307(5709):528-30. PubMed ID: 15681372
    [No Abstract]   [Full Text] [Related]  

  • 22. Observations on the virulence and the antigenic characters of cloned and uncloned lines of the Anka isolate of Plasmodium berghei. 1. Production of recrudescent parasitaemias in immunized mice.
    Wery M; Weyn J; Timperman G; Hendrix L
    Ann Soc Belg Med Trop; 1979; 59(4):347-60. PubMed ID: 396895
    [No Abstract]   [Full Text] [Related]  

  • 23. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria.
    Yadava A; Nurmukhambetova S; Pichugin AV; Lumsden JM
    J Infect Dis; 2012 May; 205(9):1456-63. PubMed ID: 22457289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Rowson-Parr virus on the severity of malaria in mice.
    Cox FE; Wedderburn N; Salaman MH
    J Gen Microbiol; 1974 Dec; 85(2):358-64. PubMed ID: 4375171
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
    van der Velden M; Rijpma SR; Verweij V; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Franke-Fayard BM; Russel FG; Janse CJ; Sauerwein RW; Koenderink JB
    Am J Trop Med Hyg; 2016 Aug; 95(2):378-82. PubMed ID: 27296385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host immune response and pathological expression in malaria: possible implications for malaria vaccines.
    Grau GE; Del Giudice G; Lambert PH
    Parasitology; 1987; 94 Suppl():S123-37. PubMed ID: 2438630
    [No Abstract]   [Full Text] [Related]  

  • 27. Observations on the virulence and the antigenic characters of cloned and uncloned lines of the Anka isolate of Plasmodium berghei. 2. Cross-protection assay with successive recrudescent populations.
    Wery M; Timperman G
    Ann Soc Belg Med Trop; 1979; 59(4):361-9. PubMed ID: 396896
    [No Abstract]   [Full Text] [Related]  

  • 28. [Malaria in the municipality of Humaitá, State of Amazonas. V - Serological aspects of Plasmodium falciparum and Plasmodium berghei antigens].
    Salata E; Correa FM; Sogayar R; Ramos MA; Meira DA; Barraviera B; Vadileti C; Pirolla JA
    Rev Inst Med Trop Sao Paulo; 1981; 23(5 Suppl 5):32-6. PubMed ID: 7046014
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody responses of patients with natural malaria to human and simian plasmodium antigens measured by the fluorescent antibody test.
    Meuwissen JH
    Trop Geogr Med; 1968 Jun; 20(2):137-40. PubMed ID: 4968381
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the role of antibodies against sporozoites in Plasmodium berghei malaria.
    Golenser J; Verhave JP; De Valk J; Heeren J; Meuwissen JH
    Isr J Med Sci; 1978 May; 14(5):606-10. PubMed ID: 355196
    [No Abstract]   [Full Text] [Related]  

  • 31. The sensitivity of some human and simian Haemosporidial antigens to detect fluorescent antibodies against human Plasmodia.
    Matola YG; Lelijveld J; Kortmann HF; Meuwissen JH
    East Afr Med J; 1973 Jun; 50(6):294-9. PubMed ID: 4126540
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibodies against sporozoites of human and simian malaria produced in rats.
    Nussenzweig RS; Montuori W; Spitalny GL; Chen D
    J Immunol; 1973 Feb; 110(2):600-1. PubMed ID: 4405323
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
    Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
    Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoprophylaxis of malaria: sporozoite-induced immunity.
    Nussenzweig RS
    Adv Exp Med Biol; 1977; 93():75-87. PubMed ID: 413344
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulation of resistance in mice to sporozoite-induced Plasmodium berghei malaria by injections of avian exoerythrocytic forms.
    Holbrook TW; Spitalny GL; Palczuk NC
    J Parasitol; 1976 Oct; 62(5):670-5. PubMed ID: 789848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a sporozoite malaria vaccine.
    Nussenzweig V; Nussenzweig RS
    Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advances in malaria research: parasite biology, chemotherapy and host/parasite relationships.
    Trigg PI
    Ann Ist Super Sanita; 1985; 21(3):271-90. PubMed ID: 3914847
    [No Abstract]   [Full Text] [Related]  

  • 39. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
    de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
    Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective activity in sera from mice immunized against Plasmodium berghei.
    Wells RA; Diggs CL
    J Parasitol; 1976 Aug; 62(4):638-9. PubMed ID: 784936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.